Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 32% ± 13% | |
microglial cell | 10 studies | 37% ± 16% | |
macrophage | 9 studies | 29% ± 11% | |
B cell | 8 studies | 24% ± 9% | |
adipocyte | 7 studies | 23% ± 5% | |
astrocyte | 7 studies | 32% ± 11% | |
classical monocyte | 6 studies | 23% ± 7% | |
endothelial cell | 6 studies | 26% ± 9% | |
myeloid cell | 6 studies | 21% ± 3% | |
dendritic cell | 6 studies | 25% ± 7% | |
type I pneumocyte | 6 studies | 28% ± 6% | |
fibroblast | 6 studies | 18% ± 3% | |
pro-B cell | 5 studies | 31% ± 9% | |
plasmacytoid dendritic cell | 5 studies | 25% ± 3% | |
naive B cell | 4 studies | 19% ± 5% | |
precursor B cell | 4 studies | 32% ± 3% | |
epithelial cell | 4 studies | 26% ± 6% | |
ciliated cell | 4 studies | 27% ± 7% | |
GABAergic neuron | 4 studies | 35% ± 12% | |
glutamatergic neuron | 4 studies | 46% ± 12% | |
monocyte | 4 studies | 33% ± 7% | |
conventional dendritic cell | 3 studies | 32% ± 7% | |
neuron | 3 studies | 33% ± 18% | |
Mueller cell | 3 studies | 22% ± 2% | |
retinal pigment epithelial cell | 3 studies | 25% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 8% | |
alveolar macrophage | 3 studies | 39% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3207.16 | 1445 / 1445 | 100% | 28.92 | 183 / 183 |
thymus | 100% | 4605.68 | 653 / 653 | 100% | 39.75 | 605 / 605 |
lung | 100% | 4546.03 | 578 / 578 | 100% | 28.02 | 1154 / 1155 |
intestine | 100% | 2893.39 | 966 / 966 | 99% | 19.23 | 524 / 527 |
uterus | 100% | 2237.81 | 170 / 170 | 99% | 27.19 | 455 / 459 |
ovary | 100% | 2117.97 | 180 / 180 | 99% | 16.66 | 426 / 430 |
breast | 100% | 3189.52 | 459 / 459 | 99% | 17.60 | 1106 / 1118 |
brain | 99% | 1844.66 | 2612 / 2642 | 100% | 19.31 | 705 / 705 |
pancreas | 99% | 2825.73 | 326 / 328 | 99% | 31.78 | 177 / 178 |
kidney | 100% | 2313.99 | 89 / 89 | 99% | 22.91 | 889 / 901 |
prostate | 100% | 2419.42 | 245 / 245 | 98% | 10.88 | 493 / 502 |
stomach | 99% | 1923.73 | 355 / 359 | 99% | 19.53 | 284 / 286 |
bladder | 100% | 2322.00 | 21 / 21 | 98% | 20.57 | 493 / 504 |
adrenal gland | 100% | 6639.99 | 258 / 258 | 97% | 15.94 | 223 / 230 |
skin | 100% | 4290.69 | 1809 / 1809 | 91% | 10.60 | 429 / 472 |
liver | 93% | 1223.96 | 210 / 226 | 94% | 12.76 | 383 / 406 |
adipose | 100% | 3850.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 51.72 | 29 / 29 |
spleen | 100% | 4472.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.09 | 1 / 1 |
blood vessel | 100% | 3030.10 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3183.73 | 906 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 1309.47 | 806 / 861 | 0% | 0 | 0 / 0 |
muscle | 66% | 701.33 | 526 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 2.70 | 31 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0030097 | Biological process | hemopoiesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | TTC7A |
Protein name | Tetratricopeptide repeat protein 7A (TPR repeat protein 7A) TTC7A protein Tetratricopeptide repeat domain 7A |
Synonyms | TTC7 hCG_17034 KIAA1140 |
Description | FUNCTION: Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane . The complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (Probable). In the complex, plays a central role in bridging PI4KA to EFR3B and HYCC1, via direct interactions (By similarity). . |
Accessions | I6L9J2 ENST00000461601.5 ENST00000394850.6 [Q9ULT0-4] G5E9G4 ENST00000440051.1 ENST00000319190.11 [Q9ULT0-1] Q6P0M3 ENST00000409245.5 H7C055 Q9ULT0 ENST00000409825.5 H7C1P2 A0A8V8TMV0 ENST00000441914.5 H0Y3V7 |